fb pixel
Search
Close this search box.
Search
Close this search box.

Hydrocodone Combination Products (HCP) reclassified from Schedule III to Schedule II Drugs

Table of Contents

Drug Schedules HCP document with waismann method logo

Effective October 6, 2014, hydrocodone combination products (HCP), such as Vicodin and Lortab, have been reclassified from Schedule III to Schedule II drugs. This means doctors can no longer phone in a prescription for HCP’s and that patients must present a written prescription to the pharmacist.
View our PDF of the HCP reclassification.

More To Explore

The Impact of Opioids on Dental Health

Opioids serve as potent pain relievers in medical settings, but their recreational use presents serious risks, including a variety of dental health problems. Whether prescribed for pain management or...